RaNA Therapeutics (now known as Translate Bio) acquires Shire's messenger RNA therapy platform
Client(s) RaNA Therapeutics, Inc.
Jones Day acted as IP counsel to RaNA Therapeutics, Inc. (now known as Translate Bio) in connection with its acquisition of Shire Pharmaceuticals' messenger RNA therapy platform (MRT), with lead programs in cystic fibrosis and urea cycle disorders.